Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Long-term treatment risks in multiple sclerosis: risk knowledge and risk perception in a large cohort of mitoxantrone-treated patients.
The Gut Microbiome and the Brain.
Longitudinal association between depressive symptoms and walking impairment in people with relapsing-remitting multiple sclerosis.
Assessment of immune functions and MRI disease activity in relapsing-remitting multiple sclerosis patients switching from natalizumab to fingolimod (ToFingo-Successor).
Treg cell resistance to apoptosis in DNA vaccination for experimental autoimmune encephalomyelitis treatment.
Serial proton MR spectroscopy of gray and white matter in relapsing-remitting MS.
Pharmacodynamic models for discrete data.
A case of prolonged delayed postdural puncture headache in a patient with multiple sclerosis exacerbated by air travel.
Multiple sclerosis, relapses, and the mechanism of action of adrenocorticotropic hormone.
Effects of a resistance training program and subsequent detraining on muscle strength and muscle power in multiple sclerosis patients.
Suppressed pro-inflammatory properties of circulating B cells in patients with multiple sclerosis treated with fingolimod, based on altered proportions of B-cell subpopulations.
Role of SFB in autoimmune arthritis: An example of regulation of autoreactive T cell sensitivity in the gut.
Novel oxazolo-oxazole derivatives of FTY720 reduce endothelial cell permeability, immune cell chemotaxis and symptoms of experimental autoimmune encephalomyelitis in mice.
Differential Cerebellar Functional Interactions during an Interference Task across Multiple Sclerosis Phenotypes.
Therapeutic Yoga: Symptom Management for Multiple Sclerosis.
MMP-9 in Translation: From Molecule to Brain Physiology, Pathology and Therapy.
Risk genes associated with pediatric-onset MS but not with monophasic acquired CNS demyelination.
Trunk muscle activity during walking in persons with multiple sclerosis: The influence of body weight support.
Bilateral Vision Loss Responsive to Corticosteroids.
Early onset multiple sclerosis has worse prognosis than adult onset multiple sclerosis based on cognition and magnetic resonance imaging.
Spasticity in multiple sclerosis: results of a patient survey.
Management of Secondary Progressive Multiple Sclerosis: Prophylactic Treatment-Past, Present, and Future Aspects.
The multiple sclerosis drug fingolimod (FTY720) stimulates neuronal gene expression, axonal growth and regeneration.
Cognition, mood, and purpose in life in neuromyelitis optica spectrum disorder.
Occurrence and long-term outcome of tumefactive demyelinating lesions in multiple sclerosis.

Pages